Compare ADMA Biologics Inc (ADMA) vs Mercadolibre Inc (MELI) Price & Performance

ADMA Biologics IncTrade

Mercadolibre IncTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Mercadolibre Inc — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Mercadolibre Inc trades at $1,882 (market cap $98.35B). The key difference: Mercadolibre Inc is far larger — about 44.3× ADMA Biologics Inc's market cap, and Mercadolibre Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

	ADMA	MELI
Market Cap	$2.22B	$98.35B
Sector	Health	Consumer Cyclical
52-Week High	$20.38	$2.51K
52-Week Low	$7.60	$1.55K
Enterprise Value	$2.29B	$106.00B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ADMA Biologics Inc

No Aura AI signal available yet.

Mercadolibre Inc

MercadoLibre (MELI) trades at $1,824.34, up 0.2% with a bearish technical signal despite strong fundamentals. The company reported Q2 2026 EPS of $9.19, beating estimates by 6.2%, while revenue grew 50% year-over-year. Operating cash flow reached $12.12 billion in 2025, supporting aggressive growth investments. Analyst consensus remains strongly bullish with a $2,150 price target, though margin compression from strategic spending presents near-term headwinds.

MELI's growth-first strategy drives market share gains but pressures profitability, with net margin declining to 5.3%. The stock offers 18% upside to consensus target but faces execution risk in balancing expansion with returns. Competitive threats from global e-commerce players and Latin American economic volatility require monitoring. Long-term prospects remain positive given ecosystem strength and dominant market position.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ADMA

Investigation launched into ADMA Biologics for alleged channel-stuffing to boost ASCENIV sales.Newsfile Corp · 4 hours agoBearish View details →

MELI

Sea Limited shares jump 13.8% after strong Q1 revenue growth and reinvestment strategy24/7 Wall Street · 23 hours agoBullish View details →

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

About Mercadolibre Inc

MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.